These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39265563)

  • 21. Skeletal Muscle Mass Before Second-line Chemotherapy Correlates With Subsequent Prognosis and Rate of Late-line Chemotherapy in Patients With Unresectable Gastric Cancer.
    Matsunaga T; Satio H; Sakano YU; Makinoya M; Shimizu S; Shishido Y; Miyatani K; Kono Y; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    Anticancer Res; 2023 Nov; 43(11):5051-5059. PubMed ID: 37909949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observational study.
    Kim IH; Choi MH; Lee IS; Hong TH; Lee MA
    BMC Cancer; 2021 Jan; 21(1):77. PubMed ID: 33461517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between sarcopenia based on psoas muscle index and the response to nivolumab in metastatic renal cell carcinoma: A retrospective study.
    Ueki H; Hara T; Okamura Y; Bando Y; Terakawa T; Furukawa J; Harada K; Nakano Y; Fujisawa M
    Investig Clin Urol; 2022 Jul; 63(4):415-424. PubMed ID: 35796138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined test of third lumbar skeletal muscle index and prognostic nutrition index improve prognosis prediction power in resected colorectal cancer liver metastasis.
    Lv Y; Ji ML; Feng QY; Zhu DX; Lin SB; Mao YH; Xu YQ; Zheng P; He GD; Xu JM
    Aging (Albany NY); 2019 Nov; 11(22):10301-10315. PubMed ID: 31760384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral blood nutrient indices as biomarkers for anti‑PD‑1 therapy efficacy and prognosis in patients with advanced gastric cancer.
    Wang X; Liu X; Dai H; Jia J
    Oncol Lett; 2023 Sep; 26(3):397. PubMed ID: 37600335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator.
    Chen L; Bai P; Kong X; Huang S; Wang Z; Wang X; Fang Y; Wang J
    Front Cell Dev Biol; 2021; 9():656741. PubMed ID: 33859986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative skeletal muscle index vs the controlling nutritional status score: Which is a better objective predictor of long-term survival for gastric cancer patients after radical gastrectomy?
    Zheng ZF; Lu J; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
    Cancer Med; 2018 Aug; 7(8):3537-3547. PubMed ID: 29953752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations of muscle and adipose tissue parameters with long-term outcomes in middle and low rectal cancer: a retrospective cohort study.
    Liu J; Yu X; Huang X; Lai Q; Chen J
    Cancer Imaging; 2023 Jan; 23(1):5. PubMed ID: 36635737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive Values of Preoperative Prognostic Nutritional Index and Systemic Immune-Inflammation Index for Long-Term Survival in High-Risk Non-Muscle-Invasive Bladder Cancer Patients: A Single-Centre Retrospective Study.
    Bi H; Shang Z; Jia C; Wu J; Cui B; Wang Q; Ou T
    Cancer Manag Res; 2020; 12():9471-9483. PubMed ID: 33061634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of preoperative skeletal muscle area and prognostic nutritional index values on postoperative morbidity and mortality in patients with gastric cancer: a single-center retrospective analysis.
    Tuncer K; Sert I; Kilinc G; Tugmen C; Emiroglu M
    Acta Chir Belg; 2023 Jun; 123(3):251-256. PubMed ID: 34486944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study.
    Inukai M; Nishi T; Matsuoka H; Matsuo K; Suzuki K; Serizawa A; Akimoto S; Nakauchi M; Tanaka T; Kikuchi K; Shibasaki S; Uyama I; Suda K
    BMC Cancer; 2024 Sep; 24(1):1121. PubMed ID: 39251991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low skeletal muscle density is associated with poor survival in patients who receive chemotherapy for metastatic gastric cancer.
    Hayashi N; Ando Y; Gyawali B; Shimokata T; Maeda O; Fukaya M; Goto H; Nagino M; Kodera Y
    Oncol Rep; 2016 Mar; 35(3):1727-31. PubMed ID: 26648321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation.
    Bardoscia L; Besutti G; Pellegrini M; Pagano M; Bonelli C; Bonelli E; Braglia L; Cozzi S; Roncali M; Iotti C; Pinto C; Pattacini P; Ciammella P
    Front Nutr; 2022; 9():994499. PubMed ID: 36466387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of sarcopenia in patients with lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors or immune checkpoint inhibitors.
    Lyu J; Yang N; Xiao L; Nie X; Xiong J; Liu Y; Zhang M; Zhang H; Tang C; Pan S; Liang L; Bai H; Li C; Kuang H; Li T
    Front Nutr; 2023; 10():1113875. PubMed ID: 36969820
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of bioelectrical impedance analysis and computed tomography for the assessment of muscle mass in patients with gastric cancer.
    Zuo J; Zhou D; Zhang L; Zhou X; Gao X; Hou W; Wang C; Jiang P; Wang X
    Nutrition; 2024 May; 121():112363. PubMed ID: 38359703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors.
    Chen N; Yu Y; Shen W; Xu X; Fan Y
    Clin Nutr; 2024 Jan; 43(1):142-153. PubMed ID: 38043419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skeletal muscle mass predicts the outcome of nivolumab treatment for non-small cell lung cancer.
    Tsukagoshi M; Yokobori T; Yajima T; Maeno T; Shimizu K; Mogi A; Araki K; Harimoto N; Shirabe K; Kaira K
    Medicine (Baltimore); 2020 Feb; 99(7):e19059. PubMed ID: 32049805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bidirectional association between perioperative skeletal muscle and subcutaneous fat in colorectal cancer patients and their prognostic significance.
    Yan G; Liu L; Liu M; Jiang X; Chen P; Li M; Ma Q; Li Y; Duan S; You R; Huang Y; Li Z; You D
    Front Nutr; 2024; 11():1381995. PubMed ID: 39360277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Weighing the role of skeletal muscle mass and muscle density in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: a multicenter real-life study.
    Cortellini A; Bozzetti F; Palumbo P; Brocco D; Di Marino P; Tinari N; De Tursi M; Agostinelli V; Patruno L; Valdesi C; Mereu M; Verna L; Lanfiuti Baldi P; Venditti O; Cannita K; Masciocchi C; Barile A; McQuade JL; Ficorella C; Porzio G
    Sci Rep; 2020 Jan; 10(1):1456. PubMed ID: 31996766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal Muscle Mass Index Reduction Rate as a Prognostic Indicator for Patients Undergoing Pancreatectomy for Pancreatic Cancer.
    Mita J; Maeda T; Tsujita E; Hashimoto N; Fujikawa R; Ono Y; Sakai A; Tanaka S; Matono R; Ohmine T; Kometani T; Yamaguchi S; Konishi K; Hashimoto K
    Cancer Diagn Progn; 2024; 4(3):301-308. PubMed ID: 38707741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.